Lupin receives USFDA nod for Lorazepam Oral Concentrate

Drug firm Lupin said it has received US health regulator's approval to market its generic Lorazepam Oral Concentrate in American market.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news